Acer Therapeutics Inc. (ACER)


Acer Therapeutics Inc. (ACER)

$3.27 USD

0.11 (3.48%)

Updated Sep 13 6:55pm

Add ACER to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 216 in Medical - Pharmaceuticals

See all “A” rated Strong Buy stocks

ACER Daily Price Range
ACER 52-Week Price Range

ACER Stock Chart More Charts


ACER Price/Volume Stats

Current price $3.27
Prev. close $3.16
Day low $3.13
Day high $3.35
50-day MA $2.79
200-day MA $16.23
52-week high $32.75
52-week low $1.87
Volume 78,900
Avg. volume 154,235
Dividend yield N/A
Market Cap 33.01M

Acer Therapeutics Inc. (ACER) Company Bio


Acer Therapeutics Inc., formerly Opexa Therapeutics, develops therapies for the treatment of serious ultra-rare diseases with critical unmet medical needs. The company offers Celiprolol for vascular ehlers-danlos syndrome and ACER-001 for maple syrup urine disease. It also offers advancing ACER-001 for the treatment of urea cycle disorders. The company was founded in 2013 and is based in Cambridge, Massachusetts.





ACER News Stream


Event/Time News Detail
Loading, please wait...

ACER Social Stream


Loading social stream, please wait...

View Full ACER Social Stream

ACER Returns

1-mo 56.46%
3-mo -81.24%
6-mo -86.23%
1-year -89.56%
3-year -90.92%
5-year -96.34%
YTD -83.75%
2018 45.27%
2017 45.45%
2016 -66.79%
2015 -51.91%
2014 -60.44%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.4237 seconds.